Up-Regulation of Estrogen Receptors by Nonsteroidal Antiestrogens in Human Breast Cancer

Cancer Research

Volumn 49, Issue 19, 1989, Pages 5312-5316

  Kiang, David T ^a   Kollander, Rahn E ^a   Thomas, Thresia ^a   Kennedy, B J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ESTROGEN RECEPTOR; RADIOISOTOPE; TAMOXIFEN;

BREAST CANCER; CELL CULTURE; CELL STRAIN MCF 7; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

BREAST NEOPLASMS; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; RECEPTORS, ESTROGEN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TAMOXIFEN; TIME FACTORS;

EID: 0024464667     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jensen, E. V., Block, G. E., Smith, S., Kyser, K., and DeSombre, E. R. Estrogen receptors and breast cancer response to adrenalectomy. Natl. Cancer Inst. Monogr., 34:55–70, 1971.
2. McGuire, W. L., Carbone, P. P., Sears, M. E., and Escher, G. C. Estrogen receptors in human breast cancer. An overview. In:W. L. McGuire, P. P. Carbone, and E. P. Vollmer (eds.), Estrogen Receptors in Human Breast Cancer pp. 1–7. New York:Raven Press, 1975.
3. Kiang, D. T., King, M., Zhang, HJ., Kennedy, B. J., and Wang, N. Cyclic biological expression in mouse mammary tumors. Science (Wash. DC), 216:68–70, 1982.
4. Allegra, J. C., Barlock, A., Huff, K. K., and Lippman, M. E. Changes in multiple or sequential estrogen receptor determinations in breast cancer. Cancer (Phila.), 45:792–794, 1980.
5. Markaverich, B. M., Upchurch, S., and Clark, J. H. Two binding sites for estradiol in rat uterine nuclei:relationship to stimulation and antagonism of uterine growth. In:F. Bresciani (ed.), Perspectives in Steroid Receptor Research, pp. 143–165. New York:Raven Press, 1980.
6. Umans, R. S., Weichselbaum, R. R., Johnson, C. M., and Little, J. B. Effects of estradiol concentration on levels of nuclear estrogen receptors in MCF-7 breast tumor cells. J. Steroid Biochem., 20:605–609, 1984.
7. Jordan, V. C., Dix, C. J., and Prestwich, G. Inhibition of cell division and stimulation of progesterone receptor synthesis in rat oestrogen target tissues by non-steroidal antioestrogens. Adv. Exp. Med. Biol., 117:133–155, 1979.
8. Horwitz, K. B., and McGuire, W. L. Estrogen control of progesterone receptor induction in human breast cancer role of nuclear estrogen receptor. Adv. Exp. Med. Biol., 117:95–110, 1979.
9. Koseki, Y., Zava, D. T., Chamness, G. C., and McGuire, W. L. Estrogen receptor translocation and replenishment by the antiestrogen tamoxifen. Endocrinology, 101:1104–1110, 1977.
10. Horwitz, K. B., and McGuire, W. L. Nuclear mechanisms of estrogen action:effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J. Biol. Chem., 253:8185–8191, 1978.
11. Horwitz, K. B., and McGuire, W. L. Nuclear estrogen receptors:effect of inhibitors on processing and steady state levels. J. Biol. Chem., 255:9699–9705, 1980.
12. Tate, A. C., and Jordan, V. C. Nuclear [3H]-4-hydroxytamoxifen (4-OHTAM)- and [3H]estradiol (E2)-estrogen receptor complexes in the MCF-7 breast cancer and GH3 pituitary tumor cell lines. Mol. Cell. Endocrinol., 56:211–219, 1984.
13. Eckert, R. L., Mullick, A., Rorke, E. A., and Katzenellenbogen, B. S. Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique. Endocrinology, 114:629–637, 1984.
14. Thomas, T., and Kiang, D. T. Additive growth inhibitory effects of dl-ck-difluoromethylornithine and antiestrogens on MCF-7 breast cancer cell line. Biochem. Biophys. Res. Commun., 148:1338–1345, 1987.
15. Burton, K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J., 62:315–323, 1956.
16. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193:265–275, 1951.
17. Martin, P. M., Berthois, Y., and Jensen, E. V. Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor. Proc. Natl. Acad. Sci. USA, 85:2533–2537, 1988.
18. Tate, A. C., Greene, G. L., DeSombre, E. R., Jensen, E. V., and Jordon, V. C. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor. Cancer Res., 44:1012–1018, 1984.
19. Eckert, R. L., and Katzenellenbogen, B. S. Physical properties of estrogen receptor complexes in MCF-7 human breast cancer cells. Differences with anti-estrogen and estrogen. J. Biol. Chem., 257:8840–8846, 1982.
20. Lippman, M., Bolan, G., and Huff, K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res., 36:4595–4601, 1976.
21. Katzenellenbogen, B. S., Kendra, K. L., Norman, M. J., and Berthois, Y. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res., 47:4355–4360, 1987.
22. Read, L. D., and Katzenellenbogen, B. S. Regulation of estrogen receptor, mRNA, and protein levels in human breast cancer cell lines by sex-steroid hormones, their antagonists and growth factors, p. 129. Proceedings of the 70th Annual Meeting of Endocrine Society, New Orleans, 1988.
23. Martin, M. B., Lindsey, R., Saceda, M., and Puente, M. Antiestrogen regulation of estrogen receptor expression in MCF-7 cells, p. 253. Proceedings of the 70th Annual Meetings of Endocrine Society, New Orleans, 1988.
24. Zähringer, J., Baliga, B. S., and Munro, H. N. Novel mechanism for translation control in regulation of ferritin synthesis by iron. Proc. Natl. Acad. Sci. USA, 75:857–861, 1976.
25. Hentze, M. W., Caughman, S. W., Rouault, T. A., Barriocanal, J. G., Dancis, A., Harford, J. B., and Klausner, R. D. Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science (Wash. DC), 238:1570–1573, 1987.
26. Kiang, D. T., and Kennedy, B. J. Changes of estrogen receptor (ER) status following therapy in advanced breast cancer. Proc. Am. Assoc. Cancer Res., 25:204, 1984.
27. Waseda, N., Kato, Y., Imura, H., and Kurata, M. Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer. Cancer Res., 41:1984–1988, 1981.
28. Gottardis, M. M., and Jordan, V. C., Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. Cancer Res., 48:5183–5187, 1988.
29. Eckert, R. L., and Katzenellenbogen, B. S. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. Cancer Res., 42:139–144, 1982.
30. Bardon, S., Vignon, F., Montcourrier, P., and Rochefort, H. Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res., 47:1441–1448, 1987.